Showing results (21-30 of 200) with videos related to
Sort By:
Pageof 20
Targeted Oncology|May 6, 2023
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A PodcastAdam Brufsky, Christopher GallagherBiologics : Targets & Therapy|August 27, 2009
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancerShannon Puhalla, Adam BrufskyJournal of Cancer Policy|July 28, 2022
A comparative study of cancer drug approvals in india and high-income countriesArya Mariam Roy, Rachel Jones, Aju MathewThe Lancet. Oncology|December 2, 2021
Financial toxicity in cancer care in India: a systematic reviewJeffrey Mathew Boby, Senthil Rajappa, Aju MathewInternational Journal of Cancer|May 21, 2019
More options for adjuvant treatment of HER2-positive breast cancer: How to choose wisely?Dario Trapani, Arun K A Rajasekar, Aju MathewClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2015
Can circulating tumor cells predict resistance in metastatic breast cancer?Aju Mathew, Adam M Brufsky, Nancy E DavidsonCase Reports in Oncology|December 7, 2016
Capecitabine-Induced Coronary VasospasmDanish Henry, Francine Rudzik, Allison Butts, et al.JCO Global Oncology|August 8, 2024
Young-Onset Colorectal Cancers in Men Versus Women: Is There a Difference in IncidenceJeffrey Mathew Boby, Jame Mathew Benny, Aju MathewAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Driving Evidence-Based Standardization of Care within a Framework of Personalized MedicineAdam Brufsky, Kathleen Lokay, Melissa McDonaldJournal of Oncology|March 13, 2010
Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesionsBruce Hough, Adam Brufsky, Suzanne LentzschPageof 20